Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07527143

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Status
Not Yet Recruiting
Phase
—
Study type
Observational
Enrollment
25 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
Female
Age
45 Years
Healthy volunteers
Accepted

Summary

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Conditions

Interventions

TypeNameDescription
OTHERNon-Interventional StudyNon-interventional study

Timeline

Start date
2026-04-06
Primary completion
2027-04-06
Completion
2027-04-06
First posted
2026-04-14
Last updated
2026-04-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07527143. Inclusion in this directory is not an endorsement.

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer (NCT07527143) · Clinical Trials Directory